• In May 2026, Ambarella reported first-quarter sales of US$100.36 million with a reduced net loss, issued second-quarter revenue guidance of US$105 million to US$111 million, announced a new US$50 million share repurchase program, and confirmed completion of an earlier buyback.
• The company also entered a long-term edge AI co-development and sourcing agreement with Hanwha, estimated at over US$800 million in potential revenue across more than ten years, which may influence how investors view the scale and visibility of Ambarella’s future business pipeline.
• Next, we’ll examine how the long-term Hanwha edge AI agreement reshapes Ambarella’s existing investment narrative and perceived growth drivers.

Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

Ambarella Investment Narrative Recap

To own Ambarella, you generally need to believe in growing demand for edge AI chips across security, robotics, and other connected devices, while accepting ongoing losses and heavy R&D investment. The Hanwha agreement and Q1 results may support the near term catalyst of stronger edge AI adoption, but key risks remain around IoT concentration, customer exposure in Asia, and the timing of any improvement in profitability.

Among the recent announcements, the long term Hanwha edge AI agreement stands out as most relevant. With more than US$800 million in potential revenue over 10 plus years, it highlights how Ambarella’s CVflow platform could be embedded across multiple Hanwha product lines, which may matter for investors focused on edge AI design win momentum and efforts to reduce reliance on more volatile consumer IoT demand.

Yet, despite the excitement around edge AI, investors should be aware that customer concentration and regional exposure could still...

Ambarella's narrative projects $526.3 million revenue and $74.3 million earnings by 2028. This requires 14.8% yearly revenue growth and a $162.9 million earnings increase from -$88.6 million today.

Uncover how Ambarella's forecasts yield a $97.45 fair value, a 56% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already assuming only about 12.1 percent annual revenue growth and ongoing losses, so their more cautious view on volatility and supply chain risk might shift further after this news, reminding you that expectations differ widely and are always worth comparing.

Explore 7 other fair value estimates on Ambarella - why the stock might be worth as much as 88% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Ambarella research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Ambarella research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ambarella's overall financial health at a glance.

Interested In Other Possibilities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 25 elite penny stocks that balance risk and reward.
• This technology could replace computers: discover 29 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.